Fidelity SPDR Advertisement
Home > Boards > US OTC > Delisted >

Xechem International Inc. (fka XKEM)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 11/13/2014 12:12:20 PM - Followers: 452 - Board type: Free - Posts Today: 0

                 XKEM went to heaven in 2011      

XKEM has been revoked from any trading, per the Securities and Exchange Commission.

SECURITIES EXCHANGE ACT OF 1934
Release No. 66613/March 16, 2012
ADMINISTRATIVE PROCEEDING
File No. 3-14732

http://www.sec.gov/litigation/admin/2012/34-66613.pdf



All assets were sold at auction, and all operations have ceased.

"On October 7, 2011, the 'Q' was removed from the trading symbol of XKEMQ.PK changing it to XKEM.PK.  The "Q" designation is used to indicate reorganization under the Bankruptcy Code.  On August 24, 2011, all right, title, and interest to any and all assets of Xechem International, Inc. (the "Company") and Xechem, Inc. where sold at auction, including any and all right, title and interest to Xechem (India) Pvt. Limited and Xechem Pharmaceuticals Nigeria Limited.  For further information, see case no. 08-30512 in the United States Bankruptcy Court, Northern District of Illinois (Eastern Division)."




SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K  

 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
 
Date of Report:  October 10, 2011

(Date of earliest event reported)
 
 
XECHEM INTERNATIONAL, INC.

(Exact name of registrant as specified in the charter)
 
Delaware
0-23788
22-3284403
(State or other jurisdiction of incorporation)
(Commission File No.)
(IRS Employer Identification No.)
 
1550 Main Street, Suite A3
Windsor, CO  80550  

(Address of Principal Executive Offices)
 
(970) 377-9554

Registrant's telephone number including area code)
 
New Brunswick Technology Center
100 Jersey Avenue, Building B, Suite 310
New Brunswick, New Jersey 08901-3279

(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
1

 

Section 8 - Other Events
 
Item 8.01 Other Events
 
Change of trading Symbol
On October 7, 2011, the 'Q' was removed from the trading symbol of XKEMQ.PK changing it to XKEM.PK.  The "Q" designation is used to indicate reorganization under the Bankruptcy Code.  On August 24, 2011, all right, title, and interest to any and all assets of Xechem International, Inc. (the "Company") and Xechem, Inc. where sold at auction, including any and all right, title and interest to Xechem (India) Pvt. Limited and Xechem Pharmaceuticals Nigeria Limited.  For further information, see case no. 08-30512 in the United States Bankruptcy Court, Northern District of Illinois (Eastern Division).
 
Xechem International, Inc. and Ministry of Health, Federal Republic of Nigeria .
In July 2002 the Company formed Xechem Pharmaceuticals Nigeria Limited ("Xechem
Nigeria"). On July 18, 2002, the Company signed an exclusive worldwide license agreement (the "Agreement") with the National Institute of Pharmaceutical Research and Development (Federal Ministry of Health) the Federal Republic of Nigeria, for the manufacture, marketing, distribution and sales of NIPRISAN(TM), a botanical (the "Botanical") for the treatment of Sickle Cell Disease. The Minister of Health, A.B.C. Nwosu, signed the Agreement in his capacity as Minister of Health of Nigeria.
 
The Agreement stated there were "…related patents and foreign counterpart patents thereof, and totaling forty-six (46) patents world-wide….", and the Licensor warranted that "…  LICENSED PATENTS are, each and every one, valid and enforceable in their respective jurisdictions, and that LICENSOR has maintained and shall maintain the validity and enforceability of the said PATENT RIGHTS for the term of this AGREEMENT."
 
Documents filed during the Bankruptcy proceedings of the Company disclosed licensed patents had been abandoned, and were no longer valid and enforceable, before   the Agreement was signed on July 18, 2002, and therefore there were not "forty-six (46) patents world-wide" , as the Agreement stated, when the Agreement was signed on July 18, 2002.  The Company paid licensing fees and royalty payments to the National Institute of Pharmaceutical Research and Development, and the Company invested substantial sums of money in the development of the Botanical, all under written representations contained in the Agreement signed by The Minister of Health, A.B.C. Nwosu, in his capacity as Minister of Health of Nigeria.
 
 
Item 9.01
Financial Statements and Exhibits.
 
 
(a)
Financial Statements
 
None
 
 
(b)
Exhibits
 
None
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
             
       
XECHEM INTERNATIONAL, INC.
       
Date: October 17, 2011
     
By:
 
/s/ Stephen F Burg
       
Name:
 
Stephen F Burg
       
Title:
 
Corporate Secretary
 
http://sec.gov/litigation/suspensions/2012/34-66297.pdf

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
SECURITIES EXCHANGE ACT OF 1934 Release No. 66297 / February 2, 2012
The U.S. Securities and Exchange Commission announced the temporary suspension of trading in the securities of the following issuers, commencing at 9:30 a.m. EST on February 2, 2012 and terminating at 11:59 p.m. EST on February 15, 2012:
 American Unity Investments, Inc. (AUNI)
 China Display Technologies, Inc. (CDYT)
 China Wind Energy, Inc. (CWEY)
 Fuda Faucet Works, Inc. (FUFW)
 Greater China Media & Entertainment Corp. (GTCN)
Xechem International, Inc. (XKEM)
The Commission temporarily suspended trading in the securities of the foregoing companies due to a lack of current and accurate information about the companies because they have not filed certain periodic reports with the Commission. This order was entered pursuant to Section 12(k) of the Securities Exchange Act of 1934 (Exchange Act).
The Commission cautions brokers, dealers, shareholders and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by these companies.
Brokers and dealers should be alert to the fact that, pursuant to Exchange Act Rule 15c2-11, at the termination of the trading suspensions, no quotation may be entered relating to the securities of the subject companies unless and until the broker or dealer has strictly complied with all of the provisions of the rule. If any broker or dealer is uncertain as to what is required by the rule, it should refrain from entering quotations relating to the securities of these companies that have been subject to trading suspensions until such time as it has familiarized itself with the rule and is certain that all of its provisions have been met. Any broker or dealer with questions regarding the rule should contact the staff of the Securities and Exchange Commission in Washington, DC at (202) 551-5720. If any broker or dealer enters any quotation which is in violation of the rule, the Commission will consider the need for prompt enforcement action.
If any broker, dealer or other person has any information which may relate to this matter, they should immediately contact Ansu N.
PostSubject
#203931   LOLOL...and you took the time to visit....remove your ElisComing 11/13/14 12:12:20 PM
#203930   There are 452 XKEM IH boardmarks. wEaReLeGiOn 11/13/14 11:08:13 AM
#203928   Yep.... ElisComing 07/16/14 09:46:53 AM
#203927   Baxter bought Aesrx montanus 07/16/14 05:46:42 AM
#203926   TORTS — FRAUD ElisComing 07/09/14 10:56:13 AM
#203925   http://www.njlawjournal.com/search-results-layout-page?query=Xechem&publication= montanus 07/09/14 03:58:34 AM
#203924   This complaint looks specific to Intellect and Pluristem: ElisComing 02/27/14 09:50:23 AM
#203923   Thanks for sharing Elis montanus 02/27/14 04:42:21 AM
#203922   Blast from the past...Whistleblower award claims noticed today ElisComing 02/24/14 05:12:52 PM
#203921   5Hmf is the next blockbuster drug! montanus 12/12/13 12:15:56 PM
#203920   http://clinicaltrials.gov/ct2/results?term=Aesrx&Search=Search montanus 12/09/13 05:13:23 PM
#203919   http://www.nigerianbulletin.com/threads/nigerian.research-institute-commences-pr TOCO 12/01/13 06:27:27 PM
#203918   Nice. I hope he bends over for computerguy101 09/16/13 09:15:50 AM
#203917   http://mobile.nytimes.com/2013/09/06/business/david-blech-a-biotech-king-dethron montanus 09/16/13 05:37:55 AM
#203916   http://aesrx.com/news.html#Phase2 montanus 09/04/13 12:56:56 PM
#203915   NIPRD Begins Production of Sickle Cell Drug ElisComing 08/26/13 11:28:52 AM
#203914   A lot of what happened here was criminal, IMHO. Dspetry 08/23/13 12:05:28 PM
#203913   Former ‘King of Biotech’ settles with SEC montanus 08/23/13 05:23:29 AM
#203912   Ramesh Pandey=Stay the F...?k away.......RUN don't Walk!!!!!!!! India-n BB_Blue Chip 07/20/13 02:54:46 AM
#203909   All the Best to you Steve... ElisComing 07/09/13 11:04:49 PM
#203908   Had my (5mil+) shares retired by the broker lsd673 07/09/13 10:39:11 PM
#203907   For those that still pay any attention to ElisComing 06/20/13 11:50:54 AM
#203906   I still have 2 million shares even though Derf3 06/18/13 03:23:57 PM
#203905   This company is no more. I got lucky JwJ74 05/29/13 08:01:20 AM
#203904   All kidding aside, will this stock ever trade nunze 05/25/13 05:34:47 PM
#203903   DDirect Link between XKEM and BLECH: http://www.littleindia.com/archive/dec96/su olroy 05/18/13 07:50:53 PM
#203902   chassman and blech olroy 05/18/13 05:33:19 PM
#203901   How about Chassman, What happened to her. olroy 05/18/13 05:30:35 PM
#203900   This following massage is not Off-Topic! montanus 05/17/13 02:44:36 PM
#203899   He was a heavy player in the early Dspetry 05/02/13 04:01:11 PM
#203898   David Blech gets four years... montanus 05/02/13 03:32:48 PM
#203896   ???...assets were sold Aug 24, 2011 as you ElisComing 04/12/13 03:19:05 PM
#203895   Hey Elis, there was a Xechem law regarding montanus 04/12/13 02:54:12 PM
#203894   AesRx Management? montanus 03/11/13 08:11:47 AM
#203893   FYI you can ask an Admin to change wEaReLeGiOn 03/04/13 11:41:29 AM
#203892   That is the new me the old me bbarbbee 03/02/13 05:58:56 PM
#203891   Hi old and young friends!! Been awhile--just happened bbarbbee 03/02/13 05:58:02 PM
#203890   No idea if anyone else still has "shares"... ElisComing 02/12/13 01:58:19 PM
#203889   Thank you for the info. Is anyone else Silverrush 02/12/13 01:11:47 PM
#203888   No advice, but...the stock is kaput... ElisComing 02/11/13 05:00:25 PM
#203887   Im seeking advice on what to do with Silverrush 02/11/13 03:57:17 PM
#203886   http://leadership.ng/nga/articles/45175/2013/01/16/without_research_country_cann montanus 01/23/13 07:02:14 AM
#203885   Aes-103 alias 5-hmf (Blockbuster drug) [Needle] montanus 01/14/13 05:55:06 AM
#203884   Hello Lochute, bsquareinTX 01/12/13 09:40:35 AM
#203883   Thank you, Eva! Pray you are well! LOCHUTE 01/11/13 07:37:24 PM
#203882   Hello Lochute, Raven and JJGarcia, bsquareinTX 01/11/13 07:35:51 PM
#203881   Hope you are doing well Raven! LOCHUTE 01/11/13 06:21:43 PM
#203880   You are so right Lochute! TheRaveninexile 01/11/13 04:29:30 PM
#203879   Were doing fine. Still looking for that needle jjgarcia 01/11/13 09:03:29 AM
#203878   Thank you for asking. As you know I had LOCHUTE 01/08/13 07:10:35 PM
PostSubject